BioPharma Credit (LON:BPCR - Get Free Report) shares traded up 0.7% during trading on Monday . The company traded as high as GBX 0.88 ($0.01) and last traded at GBX 0.88 ($0.01). 1,612,236 shares changed hands during mid-day trading, an increase of 85% from the average session volume of 870,677 shares. The stock had previously closed at GBX 0.87 ($0.01).
BioPharma Credit Trading Up 0.7%
The company has a market cap of £1.04 billion, a PE ratio of 10.00 and a beta of 0.22. The firm has a 50 day moving average of GBX 0.88 and a two-hundred day moving average of GBX 0.87.
About BioPharma Credit
(
Get Free Report)
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BioPharma Credit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioPharma Credit wasn't on the list.
While BioPharma Credit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
